Íæż½ã½ã

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 4 days
The Motley Fool09:30 19-Sep-24
Manufacturing Chemist12:26 18-Sep-24
Medpage Today06:41 19-Sep-24
PMLiVE12:22 17-Sep-24
London South East10:10 16-Sep-24
interactive investor04:50 18-Sep-24
Cambridge News18:08 17-Sep-24
In the last 14 days
Proactive Investors (UK)09:41 13-Sep-24
This is Money22:12 10-Sep-24
Motley Fool (UK)11:58 14-Sep-24
FierceBiotech10:07 14-Sep-24
Benzinga14:23 10-Sep-24
City AM09:07 10-Sep-24
FiercePharma19:07 15-Sep-24
IG12:14 6-Sep-24
pharmaphorum16:12 11-Sep-24
Motley Fool (UK)12:02 6-Sep-24
FierceBiotech17:29 8-Sep-24
TipRanks15:50 13-Sep-24
FiercePharma15:09 13-Sep-24
London South East09:17 13-Sep-24
Seeking Alpha14:01 12-Sep-24
GlobeNewswire (Press Release)12:31 12-Sep-24
FierceBiotech14:56 8-Sep-24
Science Media Centre10:33 11-Sep-24
Pharmaceutical Technology20:31 10-Sep-24
ShareCast12:02 10-Sep-24
BNN Bloomberg11:21 10-Sep-24
FierceBiotech12:07 9-Sep-24
Bloomberg Law19:53 10-Sep-24
BNN Bloomberg16:14 15-Sep-24
Business Wire (Press Release)15:30 15-Sep-24

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.